In this position, Mr. Klarl will be responsible for the sales efforts of Titan Spine’s line of specialized Endoskeleton interbody fusion devices. He joins Titan Spine from Spinal Kinetics, where he was responsible for a sales increase of the group’s M6 Cervical and Lumbar Artificial Discs.
More Articles on Orthopedic Devices:
International Journal of Nanosystems Publishes Paper Penned by NuOrtho’s Chief Clinical Officer
LDR Receives Approvable Letter From FDA for Mobi-C Device
Misonix Q1 Revenue Increases 42% to $4.6M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.